|
|
CARBOMER 934 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
CANDELILLA WAX Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
CARBOMER HOMOPOLYMER TYPE C Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|